208457-81-2 Usage
Uses
Used in Pharmaceutical Research:
7-Methyl-6-nitro-1H-indazole is utilized as a building block for the synthesis of new drug candidates, owing to its chemical structure and reactivity.
Used in Antimicrobial Applications:
7-Methyl-6-nitro-1H-indazole is studied for its potential antimicrobial properties, making it a candidate for the development of new antimicrobial agents to combat resistant bacteria.
Used in Antifungal Applications:
7-Methyl-6-nitro-1H-indazole has also been investigated for its antifungal properties, indicating its potential use in the development of antifungal medications to treat fungal infections.
Used in Biological Imaging:
7-Methyl-6-nitro-1H-indazole has been explored for its potential as a fluorescent dye in biological imaging applications, due to its ability to emit fluorescence when excited by light, which can be useful for visualizing cellular structures and processes.
Used in Materials Science:
7-Methyl-6-nitro-1H-indazole's unique properties also make it a promising candidate for applications in materials science, where it could be employed in the development of new materials with specific characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 208457-81-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,8,4,5 and 7 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 208457-81:
(8*2)+(7*0)+(6*8)+(5*4)+(4*5)+(3*7)+(2*8)+(1*1)=142
142 % 10 = 2
So 208457-81-2 is a valid CAS Registry Number.
208457-81-2Relevant academic research and scientific papers
RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF
-
Page/Page column 18, (2010/04/23)
Compounds of Formulas (I), (IIA) and (IIIA) are useful for inhibiting Raf kinase and for treating disorders mediated thereby. Methods of using compounds of Formulas (I), (IIA) and (IIIA) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
